Teleflex announced today that Chair, President and CEO Liam Kelly is departing the company, effective immediately.

Teleflex said the decision to move on from Kelly, who had been CEO since January 2018 and chairman since May 2022, is part of its shift to a more focused, higher-growth organization with the planned ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Teleflex cut its full-year revenue outlook for 2025, citing softer-than-expected demand and order delays. The medical-technologies company on Thursday said it now expects to report revenue of $3.27 ...

Choose Philadelphia Business Journal as a preferred news source to see more of our reporting on Google.

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026. The company’s urology, acute care, and OEM businesses will be grouped under Teleflex ...

With this transaction, Intersurgical will integrate the Acute Care and Interventional Urology product ranges, technical ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Teleflex may be enjoying improved profits and sales. But it will still lay off workers and close plants as it restructures in the face of what top executive Benson F. Smith describes as "continuing ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...